ims latin america review 2004

of 137 /137
March 15, 2022 © 2002 IMS Health Incorporated or its affiliates. All rights reserved. Strategic review of the pharmaceutical markets in the Latin America/Canada Region Prepared by IMS for Abbott - January 2004

Author: yolanda-cristina-aguiar-morazzani

Post on 16-Aug-2015

216 views

Category:

Documents


0 download

Embed Size (px)

DESCRIPTION

Revisión Mercado Latinoamericanos según IMS

TRANSCRIPT

August 15, 2015 2002 IMS Health Incorporated or its affiliates. All rights reserved.Strategic review of the pharmaceutical markets in the Latin America!anada "egionPrepared by IMS for Abbott - January 2004August #$% 20#$2 2002 IMS Health Incorporated or its affiliates. All rights reserved.Contents& Introduction ' (he )lo*al +harmaceutical Market& Latin America!anada, "egional -verview& Appendi., Latin America ' !ountr/ 0eep 0ive August #$% 20#$1 2002 IMS Health Incorporated or its affiliates. All rights reserved.(he )lo*al +harmaceutical MarketAugust #$% 20#$2 2002 IMS Health Incorporated or its affiliates. All rights reserved.Global Overview& 3orldwide industr/ growth slowed & !ost containment measures universal& "40 productivit/ slow to improve& )enerics continue to erode sales growth *ut not increase volumeSource, IMS Health, MI0AS% MA( Septem*er 2001August #$% 20#$$ 2002 IMS Health Incorporated or its affiliates. All rights reserved.!ono"i! nviron"ent& "ecover/ from the recent economic slowdown has *een slower than e.pected& )overnments are increasing spending in an effort to kick5start growth% *ut deficits are growing as a result& +erformance of the 6S econom/ will continue to have a ma7or impact on glo*al economic growth prospectsSource, IMS Health, IMS Market +rognosis )lo*al 0ata 200152008 August #$% 20#$9 2002 IMS Health Incorporated or its affiliates. All rights reserved.#orld Population 200$-200%& 3orld population to reach 9.9 *illion */ 2008 5 growth concentrated in developing regions& 0eclining *irth rates and increases in life e.pectanc/ will continue to drive a gradual shift in the glo*al demographic profile& (hese trends will continue to drive up *oth pharmaceutical consumption and the cost of healthcare provision in *oth developed and developing countriesSource, IMS Health, IMS Market +rognosis )lo*al 0ata 200152008 August #$% 20#$8 2002 IMS Health Incorporated or its affiliates. All rights reserved.&atin A"eri!a is t'e only re(ion to 'ave s'own ne(ative (rowt') -$*4+Growt'2002 - 200$,alue SalesMA- Sept 200$.Current /S0 1illion2 + S'are of #orld Mar3etAfricaAustralia #0.2 2.1:;astern ;urope #2.$ 2.apan $0.# ##.2:3estern ;urope ##1.0 2$.1:6S2#1.9 28.8:3orldwide228.2 #00.0:#0 ?e/ [email protected] 182.0 apan% !hina% Me.icoSource, IMS Health, MI0AS% MA( Septem*er 2001!anada=.1 2.#:August #$% 20#$< 2002 IMS Health Incorporated or its affiliates. All rights reserved.&atin A"eri!an and Canadian "ar3ets wort' 045*5 1illion and 06*$ 1illion7 respe!tively#orld P'ar"a!euti!al Mar3et by 8e(ion.MA- Sept 200$22#1.9##1.0$0.#2#.=#2.$#0.2 =.1#9.90.0$0.0#00.0#$0.0200.02$0.0Balue Sales C!urrent 6SD EillionF#00: G (otal 3orld Market MA( Sept 2001 G D228.2 Eillion Source, IMS Health, MI0AS% MA( Septem*er 2001Ce.cludes hospital panels for "ussia and retail panels for EelorussiaFMar3et S'are by re(ion7 MA- Sept 200$3estern ;urope2$:>apan##:6S 2apan#0.80$#0#$Asia